The HGF-MET axis is confirmed to stimulate glycolysis and glutaminolysis to function as a biogenetic source for HCC cell lines via inhibiting pyruvate dehydrogenase complex (PDHC) activating GLS. The gene discussed is MET; the disease is hepatocellular carcinoma.